South Korea · Delayed Price · Currency is KRW Genic Statistics
Total Valuation
Genic has a market cap or net worth of KRW 242.96 billion. The enterprise value is 232.42 billion.
| Market Cap | 242.96B |
| Enterprise Value | 232.42B |
Important Dates
The next estimated earnings date is Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genic has 7.82 million shares outstanding. The number of shares has increased by 7.18% in one year.
| Current Share Class | 7.82M |
| Shares Outstanding | 7.82M |
| Shares Change (YoY) | +7.18% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 5.97% |
| Float | 4.72M |
Valuation Ratios
The trailing PE ratio is 12.86.
| PE Ratio | 12.86 |
| Forward PE | n/a |
| PS Ratio | 3.11 |
| PB Ratio | 5.92 |
| P/TBV Ratio | 5.92 |
| P/FCF Ratio | 13.51 |
| P/OCF Ratio | 11.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.72, with an EV/FCF ratio of 12.93.
| EV / Earnings | 12.31 |
| EV / Sales | 2.97 |
| EV / EBITDA | 13.72 |
| EV / EBIT | 15.52 |
| EV / FCF | 12.93 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.37 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.15 |
| Interest Coverage | 45.50 |
Financial Efficiency
Return on equity (ROE) is 59.77% and return on invested capital (ROIC) is 50.25%.
| Return on Equity (ROE) | 59.77% |
| Return on Assets (ROA) | 19.77% |
| Return on Invested Capital (ROIC) | 50.25% |
| Return on Capital Employed (ROCE) | 34.42% |
| Weighted Average Cost of Capital (WACC) | 12.72% |
| Revenue Per Employee | 241.35M |
| Profits Per Employee | 58.29M |
| Employee Count | 324 |
| Asset Turnover | 1.65 |
| Inventory Turnover | 6.24 |
Taxes
| Income Tax | -4.07B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.01% in the last 52 weeks. The beta is 1.55, so Genic's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | +44.01% |
| 50-Day Moving Average | 22,646.40 |
| 200-Day Moving Average | 26,105.80 |
| Relative Strength Index (RSI) | 63.54 |
| Average Volume (20 Days) | 378,680 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genic had revenue of KRW 78.20 billion and earned 18.89 billion in profits. Earnings per share was 2,414.00.
| Revenue | 78.20B |
| Gross Profit | 22.55B |
| Operating Income | 14.98B |
| Pretax Income | 14.81B |
| Net Income | 18.89B |
| EBITDA | 16.94B |
| EBIT | 14.98B |
| Earnings Per Share (EPS) | 2,414.00 |
Balance Sheet
The company has 13.25 billion in cash and 2.71 billion in debt, with a net cash position of 10.54 billion or 1,346.55 per share.
| Cash & Cash Equivalents | 13.25B |
| Total Debt | 2.71B |
| Net Cash | 10.54B |
| Net Cash Per Share | 1,346.55 |
| Equity (Book Value) | 41.05B |
| Book Value Per Share | 5,248.38 |
| Working Capital | 17.88B |
Cash Flow
In the last 12 months, operating cash flow was 20.65 billion and capital expenditures -2.67 billion, giving a free cash flow of 17.98 billion.
| Operating Cash Flow | 20.65B |
| Capital Expenditures | -2.67B |
| Depreciation & Amortization | 1.97B |
| Net Borrowing | -5.29B |
| Free Cash Flow | 17.98B |
| FCF Per Share | 2,297.83 |
Margins
Gross margin is 28.83%, with operating and profit margins of 19.15% and 24.15%.
| Gross Margin | 28.83% |
| Operating Margin | 19.15% |
| Pretax Margin | 18.95% |
| Profit Margin | 24.15% |
| EBITDA Margin | 21.67% |
| EBIT Margin | 19.15% |
| FCF Margin | 22.99% |
Dividends & Yields
Genic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.18% |
| Shareholder Yield | -7.18% |
| Earnings Yield | 7.77% |
| FCF Yield | 7.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.0103113.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0103113 |
Scores
Genic has an Altman Z-Score of 10.99 and a Piotroski F-Score of 7.
| Altman Z-Score | 10.99 |
| Piotroski F-Score | 7 |